Max Taylor is currently the Chief Financial Officer at Australian Natural Therapeutics Group (ANTG). Prior to this role, Max gained experience as a Director at KordaMentha and as the Co-Founder & Executive Director at Quipmo. Max also worked as a Manager on Secondment at National Australia Bank and as a Business Analyst at Deloitte Australia. Max holds a Bachelor of Commerce in Accounting and Finance from the University of Melbourne and has completed various finance and accounting related education programs.
This person is not in any teams
Australian Natural Therapeutics Group (ANTG)
Australian Natural Therapeutics Group (ANTG) is an internationally recognised supplier of scientifically advanced, safe, and effective plant-based medicines. Our strong commitment to locally grown and bred quality-assured medicinal cannabis is the culmination of years of research and development across plant breeding through to extraction techniques, to bring our products to market We are committed to investing in research and development, both in-house as well as partnering with key universities to undertake research and support clinical trial programs. Led by a board of skilled commercial leaders, our team also includes experienced horticulturists, scientific researchers and medical advisors.